Sialidase and malignancy: A minireview

Glycoconjugate Journal

Volumn 20, Issue 3, 2003, Pages 189-198

  Miyagi, Taeko ^a   Wada, Tadashi ^a   Yamaguchi, Kazunori ^a   Hata, Keiko ^a  

^a MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cancer; Ganglioside; Glycoprotein; Glycosylation; Metastasis; Sialic acid; Sialidase; Sialylation

Indexed keywords

GLYCOLIPID; GLYCOPROTEIN; SIALIC ACID; SIALIDASE;

CANCER; CANCER CELL; CARCINOGENESIS; CATALYSIS; CELL LEVEL; CELL MOTILITY; DRUG TARGETING; HUMAN; MAMMAL CELL; METASTASIS; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SHORT SURVEY; SIALYLATION; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; N-ACETYLNEURAMINIC ACID; NEOPLASM METASTASIS; NEOPLASMS; NEURAMINIDASE;

MAMMALIA;

EID: 3543071604     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:GLYC.0000024250.48506.bf     Document Type: Short Survey

References (92)

1. Abercrombie M, Ambrose EJ, The surface properties of cancer cells, Cancer Res 22, 525-48 (1962).
2. Weiss L, Neuraminidase, sialic acids, and cell interactions, J Natl Cancer Inst 50, 3-19 (1973).
3. Warren L, Buck CA, Tuszynski GP, Glycopeptide changes and malignant transformation, a possible role for carbohydrate in malignant behaviour, Biochim Biophys Acta 516, 97-127 (1978).
4. Dennis JW, Laferte S, Tumor cell surface carbohydrate and the metastatic phenotype, Cancer Metastasis Rev 5, 185-204 (1987).
5. Kobata A, Altered glycosylation of surface glycoproteins in tumor cells and its clinical application, Pigment Cell Res 2, 304-8 (1989).
6. Bhavanandan VP, Cancer-associated mucins and mucin-type glycoproteins, Glycobiology 1, 493-503 (1991).
7. Hakomori S, Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism, Cancer Res 56, 5309-18 (1996).
8. Hakomori S, Glycosylation defining cancer malignancy: New wine in an old bottle, Proc Natl Acad Sci USA 99, 10231-3 (2002).
9. Yogeeswaran G, Salk PL, Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines, Science 212, 1514-6 (1981).
10. Fogel M, Altevogt P, Schirrmacher V, Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation, J Exp Med 157, 371-6 (1983).
11. Collard JG, Schijven JF, Bikker A, La Riviere G, Bolscher JG, Roos E, Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas, Cancer Res 46, 3521-7 (1986).
12. Dennis JW, Lafarté S, Waghorne C, Breitman ML, Kerbel RS, β1-6 Branching of Asn-linked oligosaccharides is directly associated with metastasis, Science 236, 582-5 (1987).
13. Passaniti A, Hart GW, Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures, J Biol Chem 263, 7591-603 (1988).
14. Basu S, Basu M, Basu SS, Biological specificity of sialyltransferases. In Biology of the sialic acids, edited by Rosenberg A (Plenum Press, New York, 1995), pp. 69-94.
15. Basu S, Basu M, Dastgheib S, Hawes JW, Biosynthesis and regulation of glycoshingolipids. In Comprehensive natural products chemistry, edited by Barton D, Nakanishi K, Meth-Cohen O, vol. 3 (Pinto BM ed.). (Pergamon Press, New York, 1999), pp. 107-28.
16. Pilatte Y, Bignon J, Lambré CR, Bacterial sialidases-roles in pathogenicity and nutrition, Glycobiology 3, 201-17 (1993).
17. Saito M, Yu RK, Biochemistry and function of sialidases. In Biology of the sialic acids, edited by Rosenberg A (Plenum Press, New York, 1995), pp. 261-313.
18. Miyagi T, Wada T, Yamaguchi K, Multiple forms of mammalian sialidase and their altered expression in physiological and pathological conditions. In Sialobiology and other novel forms of glycosylation, edited by Inoue Y, Lee YC, Troy II FA (Gakushin Publishing Co., Osaka, 1999), pp. 197-205.
19. Monti E, Preti A, Venerando B, Borsani G, Recent development in mammalian sialidase molecular biology, Neurochem Res 27, 649-63 (2002).
20. Warren L, Spearing CW, Mammalian sialidase(neuraminidase), Biochem Biophys Res Commun 3, 489-92 (1960).
21. Carubelli R, Trucco RE, Caputto R, Neuraminidase activity in mammalian organs, Biochim Biophys Acta 60, 196-7 (1962).
22. Mahadevan S, Nduaguba JC, Tappel AE, Sialidase of rat liver and kidney, J Biol Chem 242, 4409-13 (1967).
23. Taha BH, Carubelli R, Mammalian neuraminidase: Intracellular distribution and changes of enzyme activity during lactation, Arch Biochem Biophys 119, 55-61 (1967).
24. Horvat A, Touster O, On the lysosomal occurance and the properties of the neuraminidase of rat liver and of Ehrlich ascites tumor cells, J Biol Chem 243, 4380-90 (1968).
25. Schengrund C-L, Rosenberg A, Intracellular location and properties of bovine brain sialidase, J Biol Chem 245, 6196-6200 (1970).
26. Schengrund C-L, Jensen DS, Rosenberg A, Localization of sialidase in the plasma membrane of rat liver cells, J Biol Chem 247, 2742-6 (1972).
27. Tettamanti G, Preti A, Lombardo A, Bonali F, Zambotti V, Parallelism of subcellular location of major particulate neuraminidase and gangliosides in rabbit brain cortex, Biochim Biophys Acta 306, 466-77 (1973).
28. Visser AEP, Studies on plasma membranes. XX sialidase in hepatic plasma membranes, J Membrane Biol 14, 73-84 (1973).
29. Kishore GS, Tulsiani DRP, Bhavanandan VP, Carubelli R, Membrane-bound neuraminidases of rat liver. Neuraminidase activity in Golgi apparatus, J Biol Chem 250, 2655-9 (1975).
30. Saito M, Fronda CL, Yu RK, Sialidase activity in nuclear membranes of rat brain, J Neurochem 66, 2205-8 (1996).
31. Miyagi T, Tsuiki S, Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase, Eur J Biochem 141, 75-81 (1984).
32. Miyagi T, Tsuiki S, Purification and characterization of cytosolic sialidase from rat liver, J Biol Chem 260, 6710-16 (1985).
33. Miyagi T, Sagawa J, Konno K, HandaS, Tsuiki S, Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidases from the particulate fraction of rat brain, J Biochem (Tokyo) 107, 787-93 (1990).
34. Miyagi T, Konno K, Emori Y, Kawasaki H, Suzuki K, Yasui A, Tsuiki S, Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase, J Biol Chem 268, 26435-40 (1993).
35. Ferrari J, Harris R, Warner TG, Cloning and expression of a soluble sialidase from Chinese hamster ovary cells: Sequence alignment similarities to bacterial sialidases, Glycobiology 4, 367-73 (1993).
36. Monti L, Rossi PA, Ballabio L, Borsani A, Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases, Genomics 57, 137-43 (1999).
37. Fronda CL, Zeng G, Gao L, Yu RK, Molecular cloning and expression of mouse brain sialidase, Biochem Biophys Res Commun 258, 727-31 (1999).
38. Hasegawa T, Yamaguchi K, Wada T, Takeda A, Itoyama Y, Miyagi T, Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation, J Biol Chem 275, 8007-15 (2000).
39. Kotani K, Kuroiwa A, Saito T, Matsuda Y, Koda T, K-Ochiai S, Cloning, chromosomal mapping, and characteristic 5′-UTR sequence of murine cytosolic sialidase, Biochem Biophys Res Commun 286, 250-8 (2001).
40. d'Azzo A, Hoogeveen A, Reuser AJ, Robinson D, Galjaard H, Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man, Proc Natl Acad Sci USA 79, 4535-9 (1982).
41. van der Horst GT, Galjart NJ, d'Azzo A, Galjaard H, Verheijen FW, Identification and in vitro reconstitution of lysosomal neuraminidase from human placenta, J Biol Chem 264, 1317-22 (1989).
42. Bonten E, van der Spoel A, Fornerod M, Grosveld G, d'Azzo A, Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis, Genes Dev 10, 3156-69 (1996).
43. Milner CM, Smith SV, Carrillo MB, Taylor GL, Hollinshead M, Campbell RD, Identification of a sialidase encoded in the human major histocompatibility complex, J Biol Chem 272, 4549-58 (1997).
44. Pshezhetsky AV, Richard C, Michaud L, Igdoura S, Wang S, Elsliger MA, Qu J, Leclerc D, Gravel R, Dallaire L, Potier M, Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis, Nat Genet 15, 316-20 (1997).
45. Carrillo MB, Milner CM, Ball ST, Snoek M, Campbell RD, Cloning and characterization of a sialidase from the murine histocompatibility-2 complex: Low levels of mRNA and a single amino acid mutation are responsible for reduced sialidase activity in mice carrying the Neula allele, Glycobiology 7, 975-86 (1997).
46. Igdoura SA, Gafuik C, Mertineit C, Saberi F, Pshezhetsky AV, Potier M, Trasler JM, Gravel RA, Cloning of the cDNA and gene encoding mouse lysosomal sialidase and correction of sialidase deficiency in human sialidosis and mouse SM/J fibroblasts, Hum Mol Genet 7, 115-21 (1998).
47. Rottier RJ, Bonten E, d'Azzo A, Hum Mol Genet. A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse, 7, 313-21 (1998).
48. van der Spoel A, Bonten E, d'Azoo A, Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A, EMBO J 17, 1588-97 (1998).
49. Lukong KE, Seyrantepe V, Landry K, Trudel S, Ahmad A, Gahl WA, Lefrancois S, Morales CR, Pshezhetsky AV, Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail, J Biol Chem 276, 46172-81 (2001).
50. Miyagi T, Wada T, Iwamatsu A, Hata K, Yoshikawa Y, Tokuyama S, Sawada M, Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides, J Biol Chem 274, 5004-11 (1999).
51. Hata K, Wada T, Hasegawa A, Kiso M, Miyagi T, Purification and characterization of a membrane-associated ganglioside sialidase from bovine brain, J Biochem (Tokyo) 123, 899-905 (1998).
52. Wada T, Yoshikawa Y, Tokuyama S, Kuwabara M, Akita H, Miyagi T, Cloning, expression, and chromosomal mapping of a human ganglioside sialidase, Biochem Biophys Res Commun 261, 21-7 (1999).
53. Monti E, Bassi MT, Papini N, Riboni M, Manzoni M, Venerando B, Croci G, Preti A, Ballabio A, Tettamanti G, Borsani G, Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane, Biochem J 349, 343-51 (2000).
54. Hasegawa T, Feijoo Carnero C, Wada T, Itoyama Y, Miyagi T, Differential expression of three sialidase genes in rat development, Biochem Biophys Res Commun 280, 726-32 (2001).
55. Roggentin P, Rothe B, Lottspeich F, Schauer R, Cloning and sequencing of a Clostridium perfringens sialidase gene, FEBS Lett 238, 31-4 (1988).
56. Hoyer LL, Hamilton AC, Steenbergen SM, Vimr ER, Cloning, sequencing and distribution of the Salmonella typhimurium LT2 sialidase gene, nanH, provides evidence for interspecies gene transfer, Mol Microbiol 6, 873-84 (1992).
57. Crennell SJ, Garman EF, Laver WG, Vimir ER, Taylor GL, Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase, Proc Natl Acad Sci USA 90, 9852-6 (1992).
58. Wang Y, Yamaguchi K, Shimada Y, Zhao X, Miyagi T, Site-directed mutagenesis of human membrane-associated ganglioside sialidase: Identification of amino-acid residues contributing to substrate specificity, Eur J Biochem 268, 2201-8 (2001).
59. Sato K, Miyagi T, Genomic organization and the 5′-upstream sequence of the rat cytosolic sialidase gene, Glycobiology 5, 511-6 (1995).
60. Sato K, Miyagi T, Involvement of an endogenous sialidase in skeletal muscle cell differentiation, Biochem Biophys Res Commun 221, 826-30 (1996).
61. Landolfi NF, Leone J, Womack JE, Cook RG, Activation of T lymphocytes results in an increase in H-2-encoded neuraminidase, Immunogenetics 22, 159-67 (1985).
62. Chen XP, Enioutina EY, Daynes RA, The control of IL-4 gene expression in activated murine T lymphocytes: A novel role for neu-1 sialidase, J Immunol 158, 3070-80 (1997).
63. Chen XP, Ding X, Daynes RA, Ganglioside control over IL-4 priming and cytokine production in activated T cells, Cytokine 12, 972-85 (2000).
64. Yamamoto N, Kumashiro R, Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells, J Immunol 151, 2794-802 (1993).
65. Yamamoto N, Naraparaju VR, Role of vitamin D3-binding protein in activation of mouse macrophages, J Immunol 157, 1744-9 (1996).
66. Usuki S, Hoops P, Sweeley CC, Growth control of human foreskin fibroblasts and inhibition of extracellular sialidase activity by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, J Biol Chem 263, 10595-9 (1988).
67. Kopitz J, von Reitzenstein C, Muhl C, Cantz M, Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation, Biochem Biophys Res Commun 199, 1188-93 (1994).
68. Kopitz J, Muhl C, Ehemann V, Lehmann C, Cantz M, Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells, Eur J Cell Biol 73, 1-9 (1997).
69. Kopitz J, von Reitzenstein C, Burchert M, Cantz M, Gabius HJ, Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture, J Biol Chem 273, 11205-11 (1998).
70. Kopitz J, von Reitzenstein C, Andre S, Kaltner H, Uhl J, Ehemann V, Cantz M, Gabius HJ, Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3, J Biol Chem 276, 35917-23 (2001).
71. Proshin S, Yamaguchi K, Wada T, Miyagi T, Modulation of neuritogenesis by ganglioside-specific sialidase (Neu 3) in human neuroblastoma NB-1 cells, Neurochem Res 27, 841-6 (2002).
72. Rodriguez JA, Piddini E, Hasegawa T, Miyagi T, Dotti CG, Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture, J Neurosci 21, 8387-95 (2001).
73. Kalka D, von Reitzenstein C, Kopitz J, Cantz M, The plasma membrane ganglioside sialidase cofractionates with markers of lipid rafts, Biochem Biophys Res Commun 283, 989-93 (2001).
74. Wang Y, Yamaguchi K, Wada T, Hata K, Zhao X, Fujimoto T, Miyagi T, A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains, J Biol Chem 277, 26252-9 (2002).
75. Sun P, Wang XQ, Lopatka K, Bangash S, Paller AS, Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling, J Invest Dermatol 119, 107-17 (2002).
76. Schengrund CL, Lausch RN, Rosenberg A, Sialidase activity in transformed cells, J Biol Chem 248, 4424-8 (1973).
77. Bosmann HB, Hall TC, Enzyme activity in invasive tumors of human breast and colon, Proc Natl Acad Sci USA 71, 1833-7 (1974).
78. Yogeeswaran G, Hakomori S, Cell contact-dependent ganglioside changes in mouse 3T3 fibroblasts and a suppressed sialidase activity on cell contact, Biochemistry 14, 2151-6 (1975).
79. Nojiri N, Takaku F, Tetsuka T, Saito M, Stimulation of sialidase activity during cell differentiation of human promyelocytic leukemia cell line HL-60, Biochem Biophys Res Commun 104, 1239-46 (1982).
80. Miyagi T, Goto T, Tsuiki S, Sialidase of rat hepatomas: Qualitative and quantitative comparison with rat liver sialidase, Gann 75, 1076-82 (1984).
81. Miyagi T, Konno K, Sagawa J, Tsuiki S, Neoplastic alteration of a membrane-associated sialidase of rat liver, Jpn J Cancer Res 81, 915-9 (1990).
82. Miyagi T, Sagawa J, Kuroki T, Matsuya Y, Tsuiki S, Tumor-promoting phorbol ester induces alterations of sialidase and sialyltransferase activities of JB6 cells, Jpn J Cancer Res 81, 1286-92 (1990).
83. Miyagi T, Sato K, Hata K, Taniguchi S, Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal-type sialidase activity, FEBS Lett 349, 255-9 (1994).
84. Martinez-Zorzano VS, Feijoo C, Paez de la Cadena M, Butron M, Fernandez-Briera A, Rodriguez-Berrocal FJ, Human colon sialidase: Characterization and activity levels in normal mucosa and colonic adenocarcinoma, Enzyme Protein 48, 282-90 (1994).
85. Sawada M, Moriya S, Saito S, Shineha R, Satomi S, Yamori T, Tsuruo T, Kannagi R, Miyagi T, Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression, Int J Cancer 97, 180-85 (2002).
86. Tokuyama S, Moriya S, Taniguchi S, Yasui A, Miyazaki J, Orikasa S, Miyagi T, Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA, Int J Cancer 73, 410-5 (1997).
87. Gillard BK, Thurmon LT, Marcus DM, Variable subcellular localization of glycosphingolipids, Glycobiology 3, 57-67 (1993).
88. Sakakibara K, Momoi T, Uchida T, Nagai Y, Evidence for association of glycosphingolipid with a colchicine-sensitive microtubule-like cytoskeletal structure of cultured cells, Nature 293, 76-8 (1981).
89. Gillard BK, Thurmon LT, Marcus DM, Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells, Cell Motil Cytoskeleton 21, 255-71 (1992).
90. Meuillet EJ, Kroes R, Yamamoto H, Warner TG, Ferrari J, Mania-Farnell B, George D, Rebbaa A, Moskal JR, Bremer EG, Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431, Cancer Res 59, 234-40 (1999).
91. Kato T, Wang Y, Yamaguchi K, Milner CM, Shineha R, Satomi S, Miyagi T, Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells, Int J Cancer 92, 797-804 (2001).
92. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, Miyagi T, Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression, Proc Natl Acad Sci USA 99, 10718-23 (2002).